Literature DB >> 8227190

Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells.

M Shioide1, M Noda.   

Abstract

Endothelins (ETs) are vasoconstrictive peptides produced mainly by endothelial cells. The ET receptors are expressed in many types of cells including osteoblast-like cells. The purpose of this study was to examine the effects of endothelin on the expression of osteoblastic phenotype-related genes. We found that endothelin-1 (ET-1) enhanced approximately two-fold the mRNA expression of both osteopontin and osteocalcin genes in rat osteoblastic osteosarcoma ROS17/2.8 cells. These effects were dose-dependent, peaking at 10(-7) M. The ET-1 enhancement of the abundance of osteopontin and osteocalcin mRNAs was time-dependent, with a maximal effect at 24 h. ET-1 modulation of the expression of the two phenotype-related gene products of osteoblasts suggests that endothelin is one of the cytokines which modulate osteoblastic functions and that this molecule may play a role in the regulation of bone metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227190     DOI: 10.1002/jcb.240530211

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Detection and characterization of endothelin in transformed human osteoblast cell culture medium.

Authors:  H C Lam; J K Lee; K H Lai
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

Review 2.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

3.  Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease.

Authors:  Simon W Rabkin
Journal:  Int J Nephrol       Date:  2011-05-31

4.  Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects.

Authors:  Hasan Hilmi Muratli; Levent Celebi; Onur Hapa; Ali Biçimoğlu
Journal:  BMC Musculoskelet Disord       Date:  2005-09-20       Impact factor: 2.362

5.  Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption.

Authors:  J W Chiao; B S Moonga; Y M Yang; R Kancherla; A Mittelman; J R Wu-Wong; T Ahmed
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

6.  Milk fat globule-EGF factor VIII attenuates CNS injury by promoting neural stem cell proliferation and migration after cerebral ischemia.

Authors:  Cletus Cheyuo; Monowar Aziz; Weng-Lang Yang; Asha Jacob; Mian Zhou; Ping Wang
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.

Authors:  Z L Neumann; H C Pondenis; A Masyr; M L Byrum; K L Wycislo; T M Fan
Journal:  J Vet Intern Med       Date:  2015-10-01       Impact factor: 3.333

8.  Endothelial cells and endothelin‑1 promote the odontogenic differentiation of dental pulp stem cells.

Authors:  Mingyue Liu; Lin Zhao; Junlong Hu; Lihua Wang; Ning Li; Di Wu; Xin Shi; Mengtong Yuan; Weiping Hu; Xiaofeng Wang
Journal:  Mol Med Rep       Date:  2018-05-17       Impact factor: 2.952

9.  Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma.

Authors:  Javier Muñoz-Garcia; Jorge William Vargas-Franco; Bénédicte Brounais-Le Royer; Denis Cochonneau; Jérôme Amiaud; Marie-Françoise Heymann; Dominique Heymann; Frédéric Lézot
Journal:  Cancers (Basel)       Date:  2022-03-30       Impact factor: 6.639

10.  Endothelin receptors as novel targets in tumor therapy.

Authors:  Anna Bagnato; Pier Giorgio Natali
Journal:  J Transl Med       Date:  2004-05-27       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.